Cardiogen 20mg (Bioregulator)

$65.00

Cardiogen 20mg is the synthetic Khavinson short-peptide bioregulator derived from cardiac-muscle tissue fractions, for in-vitro and preclinical cardiomyocyte research. Greater than 99 percent HPLC verified.

Peptide Science research editorial team.

Cardiogen 20mg (Bioregulator) Overview

Cardiogen 20mg from Peptide Science is the synthetic Khavinson short-peptide bioregulator derived from cardiac-muscle tissue fractions, supplied as a lyophilised vial for in-vitro and preclinical cardiomyocyte and cardiovascular research. The 20 mg pack is the standard single-vial format for the Khavinson bioregulator series.

Khavinson Short-Peptide Class Background

Cardiogen 20mg (Bioregulator) belongs to the Khavinson short-peptide family, a class of synthetic two-to-four-residue peptides originally derived from bioregulator-fraction extracts of mammalian tissues by V. Kh. Khavinson and colleagues from the 1980s onward. The class is characterised by short sequence length (typically 2 to 4 amino acids), organ-specific source-tissue derivation, and synthetic reconstitution of the original tissue-fraction activity. The full class includes Epithalon (pineal), Cortexin (cerebral cortex), Pinealon (pineal), Vesugen (vascular), and the dozen organ-specific bioregulators in this catalogue.

Cardiac Bioregulator Research Context

Cardiogen is studied in preclinical research for effects on cardiomyocyte signalling pathways and cardiac-tissue regeneration models. The compound is one of the cardiovascular-targeted members of the Khavinson family alongside Vesugen, which targets vascular endothelial pathways. Browse the broader bioregulator peptide range for related Khavinson short peptides.

Vial Specifications

Cardiogen 20mg (Bioregulator) research specifications
Property Value
Compound Cardiogen 20mg (Bioregulator)
Class Khavinson short-peptide bioregulator
Source-tissue derivation Cardiac-muscle tissue fraction
Supplied form Lyophilised powder, sealed vial
Strength 20 mg per vial
Purity greater than 99 percent (HPLC verified)
Storage 2 to 8 degrees Celsius lyophilised; minus 20 degrees Celsius long-term

For paired vascular-system research with the related vascular bioregulator, see Vesugen 20mg.

Reconstitution and Handling

The lyophilised short peptide reconstitutes with bacteriostatic water at the working concentration set by the principal investigator. Aliquoting reconstituted stock for single-use frozen storage is the standard handling practice cited in Khavinson-tradition research protocols.

Quality and Shipping

Each batch passes HPLC at greater than 99 percent purity, with mass-spectrometry identity confirmation. A Certificate of Analysis accompanies every order. Material is filled in a US laboratory under ISO 9001:2015-aligned quality systems and dispatched in temperature-monitored insulated packaging via overnight or two-day courier.

For laboratory research and development use only. Not for human or veterinary consumption. Has not been evaluated by the U.S. Food and Drug Administration and is not intended to diagnose, treat, cure, or prevent any disease. Purchasers acknowledge they are qualified researchers age 21 or older and accept responsibility for compliance with all applicable federal, state, and local laws. Lyophilised vials store at 2 to 8 degrees Celsius; protect from light.

Reviews

There are no reviews yet.

Be the first to review “Cardiogen 20mg (Bioregulator)”

Your email address will not be published. Required fields are marked *

Scroll to Top